BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8695853)

  • 1. Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantisera.
    Simsek S; van der Schoot CE; Daams M; Huiskes E; Clay M; McCullough J; van Dalen C; Stroncek D; von dem Borne AE
    Blood; 1996 Aug; 88(4):1350-8. PubMed ID: 8695853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alloantibody anti-Mart interferes with Mac-1-dependent leukocyte adhesion.
    Sachs UJ; Chavakis T; Fung L; Lohrenz A; Bux J; Reil A; Ruf A; Santoso S
    Blood; 2004 Aug; 104(3):727-34. PubMed ID: 15073035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of antibodies to the C-terminal region of the integrin beta 2 subunit reveals regions that become exposed upon receptor activation.
    Lu C; Ferzly M; Takagi J; Springer TA
    J Immunol; 2001 May; 166(9):5629-37. PubMed ID: 11313403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular nature of granulocyte antigens.
    Bux J
    Transfus Clin Biol; 2001 Jun; 8(3):242-7. PubMed ID: 11499969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells.
    Weber S; Babina M; Feller G; Henz BM
    Scand J Immunol; 1997 May; 45(5):471-81. PubMed ID: 9160089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the CD11a (alpha L, LFA-1 alpha) integrin gene promoter.
    Nueda A; López-Cabrera M; Vara A; Corbí AL
    J Biol Chem; 1993 Sep; 268(26):19305-11. PubMed ID: 8103515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene frequencies of the HNA-4a and -5a neutrophil antigens in Brazilian persons and a new polymerase chain reaction-restriction fragment length polymorphism method for HNA-5a genotyping.
    Cardone JD; Bordin JO; Chiba AK; Norcia AM; Vieira-Filho JP
    Transfusion; 2006 Sep; 46(9):1515-20. PubMed ID: 16965578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies.
    Tamatani T; Kotani M; Miyasaka M
    Eur J Immunol; 1991 Mar; 21(3):627-33. PubMed ID: 1672643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cell adhesion by changes in alpha L beta 2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction.
    Peter K; O'Toole TE
    J Exp Med; 1995 Jan; 181(1):315-26. PubMed ID: 7807011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of granulocyte polymorphisms.
    Bux J
    Vox Sang; 2000; 78 Suppl 2():125-30. PubMed ID: 10938941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mutations in two patients with leukocyte adhesion deficiency and their functional correlates.
    Wardlaw AJ; Hibbs ML; Stacker SA; Springer TA
    J Exp Med; 1990 Jul; 172(1):335-45. PubMed ID: 1694220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.
    Schuh AC; Watkins NA; Nguyen Q; Harmer NJ; Lin M; Prosper JY; Campbell K; Sutherland DR; Metcalfe P; Horsfall W; Ouwehand WH
    Blood; 2002 Mar; 99(5):1692-8. PubMed ID: 11861285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia.
    Noris P; Simsek S; de Bruijne-Admiraal LG; Porcelijn L; Huiskes E; van der Vlist GJ; van Leeuwen EF; van der Schoot CE; von dem Borne AE
    Blood; 1995 Aug; 86(3):1019-26. PubMed ID: 7620155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic cause of leukocyte adhesion molecule deficiency. Abnormal splicing and a missense mutation in a conserved region of CD18 impair cell surface expression of beta 2 integrins.
    Nelson C; Rabb H; Arnaout MA
    J Biol Chem; 1992 Feb; 267(5):3351-7. PubMed ID: 1346613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2 (CD18) mutations abolish ligand recognition by I domain integrins LFA-1 (alpha L beta 2, CD11a/CD18) and MAC-1 (alpha M beta 2, CD11b/CD18).
    Bajt ML; Goodman T; McGuire SL
    J Biol Chem; 1995 Jan; 270(1):94-8. PubMed ID: 7814426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor.
    Schmits R; Kündig TM; Baker DM; Shumaker G; Simard JJ; Duncan G; Wakeham A; Shahinian A; van der Heiden A; Bachmann MF; Ohashi PS; Mak TW; Hickstein DD
    J Exp Med; 1996 Apr; 183(4):1415-26. PubMed ID: 8666900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional studies with antibodies to the integrin beta 2 subunit. A model for the I-like domain.
    Huang C; Zang Q; Takagi J; Springer TA
    J Biol Chem; 2000 Jul; 275(28):21514-24. PubMed ID: 10779511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the H52 epitope on the beta2 subunit is dependent on its interaction with the alpha subunits of the leukocyte integrins LFA-1, Mac-1 and p150,95 and the presence of Ca2+.
    Al-Shamkhani A; Law SK
    Eur J Immunol; 1998 Oct; 28(10):3291-300. PubMed ID: 9808198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two molecular defects in a child with leukocyte adherence deficiency.
    Back AL; Kwok WW; Hickstein DD
    J Biol Chem; 1992 Mar; 267(8):5482-7. PubMed ID: 1347532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of patients with leukocyte adhesion deficiency: genomic sequencing reveals otherwise undetectable mutations.
    Roos D; Meischl C; de Boer M; Simsek S; Weening RS; Sanal O; Tezcan I; Güngör T; Law SK
    Exp Hematol; 2002 Mar; 30(3):252-61. PubMed ID: 11882363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.